Natalizumab (BG00002, Tysabri) Study in Japanese Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

Research Site, Chiba

Research Site, Fukuoka

Research Site, Hiroshima

Research Site, Kawagoe

Research Site, Kyoto

Research Site, Morioka

Research Site, Niigata

Research Site, Osaka

Research Site, Otaku

Research Site, Sapporo

Research Site, Sendai

Research Site, Suita

Research Site, Tokorozawa

Research Site, Tokyo

Research Site, Tsukuba

Research Site, Ube

Research Site, Yokohama